Hydrophobin-Protein a Fusion Protein Produced in Plants Efficiently

Hydrophobin-Protein a Fusion Protein Produced in Plants Efficiently

International Journal of Molecular Sciences Article Hydrophobin-Protein A Fusion Protein Produced in Plants Efficiently Purified an Anti-West Nile Virus Monoclonal Antibody from Plant Extracts via Aqueous Two-Phase Separation Collin Jugler 1, Jussi Joensuu 2 and Qiang Chen 1,* 1 The Biodesign Institute and School of Life Sciences, Arizona State University, Mail Zone 5401, 1001 S. McAllister Avenue, Tempe, AZ 85287, USA; [email protected] 2 VTT Technical Research Centre of Finland Ltd, Espoo, Finland; jussi.joensuu@iki.fi * Correspondence: [email protected]; Tel.: +(480)-239-7802 Received: 2 March 2020; Accepted: 18 March 2020; Published: 20 March 2020 Abstract: The development of monoclonal antibodies (mAbs) has provided vast opportunities to treat a wide range of diseases from cancer to viral infections. While plant-based production of mAbs has effectively lowered the upstream cost of mAb production compared to mammalian cell cultures, further optimization of downstream processing, especially in extending the longevity of Protein A resin by an effective bulk separation step, will further reduce the overall prohibitive cost of mAb production. In this study, we explored the feasibility of using aqueous two-phase separation (ATPS) in capturing and separating plant-made mAbs from host proteins. Our results demonstrated that an anti-West Nile virus mAb (E16) was efficiently separated from most plant host proteins by a single ATPS step, comprising the mixing of plant extracts containing Hydrophobin-Protein A fusion protein (HPA) and E16 and the subsequent incubation with an inexpensive detergent. This simple ATPS step yielded a highly enriched E16 mAb preparation with a recovery rate comparable to that of Protein A chromatography. The ATPS-enriched E16 retained its structural integrity and was fully functional in binding its target antigen. Notably, HPA-based ATPS was also effective in enriching E16 from plant host proteins when both HPA and E16 were produced in the same leaves, supporting the potential of further streamlining the downstream purification process. Thus, ATPS based on plant-produced HPA in unpurified extract is a cost-effective yet efficient initial capture step for purifying plant-made mAbs, which may significantly impact the approach of mAb purification. Keywords: monoclonal antibody (mAb); aqueous two-phase separation (ATPS); hydrophobin; West Nile virus; plant-made antibody 1. Introduction Monoclonal antibodies (mAbs) have dramatically transformed how we approach the treatment of a myriad of diseases [1]. Examples of mAb-therapeutics include cetuximab to treat colorectal cancer [2], avelumab to treat a variety of tumors [3], and the combination of three anti-Ebola mAbs, known as ZMapp, to treat Ebola virus infection [4]. However, the high production cost of mAbs using mammalian cell-based platforms translates into a high market price for approved treatments. Plant-made mAbs have shown great potential in reducing the upstream costs of producing these valuable biologics by eliminating the need for expensive facilities, bioreactors, and culture media required for mammalian cell-based protein production [5]. Although the upstream processing costs can be addressed through plant-based expression platforms [6], the downstream processing remains essentially equivalent to the Int. J. Mol. Sci. 2020, 21, 2140; doi:10.3390/ijms21062140 www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2020, 21, 2140 2 of 12 mammalian cell-produced counterparts [7] and improvements or alternatives to the current methods could help to further reduce the overall production costs. Although Protein A affinity chromatography is a universally accepted standard purification step in mAb production, the resins for this chromatographic step are expensive and contribute significantly to the overall cost-of-goods of mAb-based drugs [8]. As a result, it is common practice to recycle and reuse the Protein A resin for mAb purification which can reduce column efficiency, as well as result in a reduction in the purity and overall recovery of the antibody [9,10]. The reduction of column efficiency is often attributed to ligand leaching, impurity build-up, restriction of pore access, and blocking access to the Protein A ligand itself [11]. Particularly relevant to plant-made mAbs, studies have shown that the presence of native plant proteins and small-molecule compounds, such as phenolics and alkaloids, in the raw plant extract can impact mAb binding to Protein A in addition to contributing to resin fouling [12–14]. Although the presence of these contaminating proteins and compounds can be reduced or eliminated by combining multiple and varying chromatography steps, prolonging the longevity of the Protein A resin of the initial capture step remains a challenge. This calls for the development of alternative strategies that can effectively enrich mAbs from plant extracts at a low cost. Aqueous two-phase separation (ATPS) has been a useful method for protein purification by taking advantage of unique characteristics of structurally different polymers to separate biomaterials [15]. In particular, thermo-separating surfactants have been used with hydrophobin tags to purify target proteins from fungi, plants, and insect cells [16–19]. Recently, it was demonstrated that a novel bifunctional fusion protein could be utilized to capture antibodies in-solution by way of a water-surfactant two-phase system. The bifunctional protein was a genetic fusion of the immunoglobulin-binding domain of Protein A from Staphylococcus aureus with a class II hydrophobin, HFBI, from Trichoderma reesei [20]. When the bifunctional fusion protein (HPA) was mixed with a mAb in solution, the mAb-HPA complex partitioned to the surfactant-rich phase due to the surfactant-like behavior induced by the hydrophobin moiety of the fusion protein. Upon removal of the residual aqueous phase, where the majority of the production host proteins reside, and after the addition of a low pH buffer to dissociate the mAb from the Protein A binding domain, the mAb was enriched and efficiently separated from most production host proteins [20]. While this strategy was successful in purifying mAbs from media of hybridoma culture, its feasibility in enriching mAbs from systems with more complex mixtures of proteins and other compounds, such as plant extract, has not been demonstrated. In the current study, we utilized the same bifunctional protein in a water-surfactant two-phase system to serve as an initial capture step in purifying plant-made mAbs. To achieve this, we transiently expressed two protein molecules separately in Nicotiana benthamiana: an anti-West Nile virus (WNV) mAb, E16, and the bifunctional fusion protein (HPA) described above, containing the antibody-binding domain of Protein A and the hydrophobin tag. When plant extracts containing E16 and HPA were mixed, E16 was efficiently separated from the majority of plant host proteins by a single ATPS step, yielding a highly enriched mAb preparation with the expected E16 function. Additionally, we explored the feasibility of co-expressing E16 and HPA in the same plant to further streamline the initial capture step. Co-expression of three polypeptides of E16 light chain (LC), heavy chain (HC) and HPA in the same plant produced two properly folded, functional proteins that interact with each other to achieve efficient separation of E16 from the host molecules. ATPS based on plant-produced HPA in unpurified extract has potential to change the way that plant-made mAb purification is approached. 2. Results and Discussion 2.1. Transient Expression of HPA and E16 mAb in N. benthamiana Transient expression of the HPA fusion protein in N. benthamiana plants was assessed with an enzyme-linked immunosorbent (ELISA) assay. The temporal expression pattern of HPA is similar to that of other proteins using MagnICON vectors [21], increasing up until 8–10 days post infiltration (DPI), where the protein level peaked at 218.7–272.9 µg/g FLW (Figure1). Previous work with a Int. J. Mol. Sci. 2020, 21, 2140 3 of 12 Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 3 of 12 diproteinfferent protein construct expression [20]. In vector addition reported to using significantly a different higher ex levelspression of expression vector, othe of ther factors same proteinsuch as constructdifferences [20 ].in In plant addition growth to usingand agroinfiltration a different expression conditions vector, may other also factorscontribute such to as the di ffdifferenceerences in in plantHPA growth accumulation and agroinfiltration in leaves. While conditions optimizing may also the contributeexpression to level the diofff thiserence protein in HPA in the accumulation MagnICON insystem leaves. is While required optimizing in future the work, expression our current level of expression this protein system in the did MagnICON provide systema sufficient is required amount in of futureHPA work,fusion our protein current for expression analyzing system its efficiency did provide in apurifying sufficient a amount plant-made of HPA mAb. fusion E16 protein was foralso analyzingtransiently its eexpressedfficiency in in purifying leaves of a N. plant-made benthamiana mAb. and E16 its was expression also transiently levels were expressed quantitated in leaves as ofwe N.reported benthamiana previouslyand its [22]. expression levels were quantitated as we reported previously [22]. Figure 1. Temporal expression pattern of Hydrogen-Protein A (HPA) fusion protein in N. benthamiana plants.Figure Leaves 1. Temporal were infiltrated expression with pattern

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    11 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us